Mimopezil

DB05520ExperimentalSmall molecule

Mimopezil is an acetylcholinesterase (AChE) inhibitor that has demonstrated potential use in the treatment of Alzheimer's disease. Mimopezil is a pro-drug that is rapidly absorbed and converted into huperzine A.

Primary indication: Investigated for use/treatment in alzheimer's disease.Curator reviewed
Formula / weight: C₂₃H₂₃ClN₂O₃ · 410.9 g/mol (avg)
Code names: DEBIO-9902 · DEBIO-9902 SR · ZT-1

Resolves to

Compound

UNII4MU6P880QLCAS180694-97-7

Structure

InChIKeyUYRWZANUXPUEPQ-ALWBHENDSA-NSMILES[H][C@@]12CC3=C(C=CC(=O)N3)[C@](CC(C)=C1)(\N=C\C1=CC(Cl)=CC(OC)=C1O)\C2=C\C

Targets

P22303ACHE

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Mimopezil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account